¡No estamos solas! Epistolary feminist spaces and the pandemic in Josephine Landertinger Forero's 2020 writing and filmmaking.

Through a feminist lens, this article focuses on two projects developed by the filmmaker and author Josephine Landertinger Forero, in which women's experiences and struggles in the context of COVID-19 become central to each narrative. Her book Cartas de cuarentena showcases a letter exchange between...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Gender Studies Vol. 34; no. 3; pp. 398 - 415
Autor principal: Valderrama-Burgos, Karol
Formato: Artículo
Publicado: Taylor & Francis Ltd Apr2025
Materias:
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:Through a feminist lens, this article focuses on two projects developed by the filmmaker and author Josephine Landertinger Forero, in which women's experiences and struggles in the context of COVID-19 become central to each narrative. Her book Cartas de cuarentena showcases a letter exchange between the filmmaker – residing in Barcelona – and the cultural journalist Lilian Contreras Fajardo – residing in Bogotá – sharing their experiences in confinement, whilst debating gender equity and feminist beliefs in response to the pandemic. Landertinger Forero's documentary project and work in progress, Ellas, yo, nosotras, emphasizes the existence and plurality of the female as the centre of the film. This film makes visible women from Spanish-speaking contexts that responded to Landertinger Forero's call – i.e., to share photos or videos made at home during lockdown and answer questions about their experiences in confinement in different roles and conditions. Thus, this article analyses the (auto)biographic nature of both cultural productions, and how they can be understood as epistolary spaces for women's agency and dialogic testimonies. In short, this article aims to evaluate how Landertinger Forero's work provides mechanisms to re-read and recognize roles and (inter)subjectivities of women in the age of COVID-19.